Business Wire

Corona Launches Plastic-Free Six Pack Rings

Jaa

Corona announced that it will pilot plastic-free six pack rings in select markets as part of the brand’s commitment with Parley for the Oceans to lead the industry with eco-friendly packaging. Both Corona and Parley have a shared mission to help protect the world’s oceans and beaches from marine plastic pollution. The partnership began with a commitment to protect 100 islands by 2020 and expands to include the pursuit of scalable innovation that can change the status quo. With roughly 8 MM metric tons of plastic entering the ocean each year1, there is a need to confront the issue on multiple fronts, which is why Corona has adopted Parley’s A.I.R. strategy to not only “avoid” and “intercept” plastic as much as possible, but also help “redesign” solutions that use the material.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181127005152/en/

(Photo: Business Wire)

(Photo: Business Wire)

“Our oceans are under attack. We are taking their life in rapid speed, destroying the chemistry that allows us to be here. Therefore we are bidding on the few who take the lead in true change. The ones who are shaping the future with us. Corona is such an Ocean Champion, a powerful ally in our war against marine plastic pollution — and in building the material revolution that will lead us beyond it. We share the goal of phasing plastic out for good, because we simply can’t afford its toxic impact anymore.” Cyrill Gutsch, Founder and CEO, Parley for the Oceans

Although Corona is primarily packaged in glass and fiberboard, the brand sees an opportunity to help redesign a common source of plastic in the category: six pack rings. The plastic-free rings being tested are made from plant-based biodegradable fibers, with a mix of by-product waste and compostable materials. If left in the environment, they break down into organic material that is not harmful to wildlife, whereas the industry standard plastic six pack rings are made from a photodegradable form of polyethylene that results in increasingly smaller pieces of plastic if not recycled. Although most plastic rings are recyclable, the reality is that the majority of all plastic ever created hasn’t been recycled2, which is the motivation for brands like Corona to pursue solutions that avoid the material entirely. That journey starts in the brand’s homeland of Mexico, where the plastic-free rings will be piloted in Tulum at the beginning of the year.

“The beach is an important part of Corona’s DNA and we have been working with Parley to address the issue on the frontlines where plastic is physically accumulating,” said Evan Ellman, Corona Better World Director. “We also recognize the influence a global brand like Corona can have on the industry, and with the support of Parley, are pursuing scalable solutions like plastic-free six pack rings that can become a new standard to avoid plastic for good.”

Since the partnership launched in 2017, Corona and Parley have conducted over three hundred clean-ups in over 15 countries, including the Maldives, Palau, Mexico, Dominican Republic, Chile, Indonesia, Italy, South Africa and Australia, with over seven thousand volunteers from more than two hundred locations participating in the project, totalling in more than three million pounds of plastic waste collected.

 
1

https://www.nationalgeographic.com/magazine/2018/06/plastic-planet-waste-pollution-trash-crisis/

2

https://www.economist.com/graphic-detail/2018/03/06/only-9-of-the-worlds-plastic-is-recycled

 

About Parley for the Oceans

Parley for the Oceans is the global network where creators, thinkers and leaders from the creative industries, brands, governments and environmental groups come together to raise awareness for the beauty and fragility of the oceans and collaborate on projects that can end their destruction. The organization has formed alliances with major corporations including adidas, Anheuser Busch InBev (Corona), American Express; the United Nations; the Maldives and collaborators spanning the worlds of science, art, fashion, design, entertainment, sports, and space and ocean exploration. To know more: www.parley.tv

About Corona

Born in Mexico, Corona is the leading beer brand in the country, the most popular Mexican beer worldwide exported to more than 180 countries. Corona Extra was first brewed in 1925 at the Cervecería Modelo in Mexico City.

Corona is a pioneer in the beer industry by being the first to use a transparent bottle showcasing its purity and high quality to the world. Each glass bottle is produced in a glass factory in Mexico owned by the brand. The artwork found on the bottle is painted, highlighting our commitment to quality in our packaging and our Mexican heritage.

No Corona is complete without the lime. Naturally adding character, flavor and refreshment, the lime ritual is an integral part of delivering an experience that is truly unique to Corona. The brand is synonymous with the beach and celebrates time outdoors. It invites people to pause, relax and enjoy the simple pleasures of life. For more visit www.corona.com

Contact information

Lauren Bishop, Alison Brod Marketing + Communications
Corona@alisonbrodmc.com | 212-230-1800

Aimee Baxter, Anheuser-Busch InBev
Aimee.Baxter@ab-inbev.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Illumina and the Lundbeck Foundation GeoGenetics Centre Collaborate to Generate One of the Largest Ancient Genome Datasets to Decode the Genetic Origins and Evolution of Mental Health Issues26.3.2019 09:00:00 EETTiedote

Illumina (NASDAQ:ILMN) and the Lundbeck Foundation GeoGenetics Centre at the University of Copenhagen, Denmark partner to explore the relationship between the evolutionary history of select mental and neurological disorders and infectious pathogens. One of the first projects of its kind worldwide, the endeavor aims to acquire new knowledge in terms of the medical and biological understanding of special factors underlying the development of human neuropsychiatric diseases through the ages. Ultimately, the project may provide a new approach to the development of medicines and other therapeutic treatments for mental and neurological conditions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190325005867/en/ Where do brain disorders come from? In an effort to shed light on the role of microbes in the pathogenesis of neuropsychiatric illnesses, such as Alzheimer’s disease and schizophrenia, Professor Eske Willerslev and his team

Earth Networks Announces Completion of Severe Weather Early Warning System for PAGASA26.3.2019 02:00:00 EETTiedote

Earth Networks announced today the completion of the Philippines’ first nationwide severe weather monitoring and alerting network with associated software services for the Philippine Atmospheric, Geophysical, and Astronomical Services Administration (PAGASA), the National Meteorological and Hydrological Services (NMHS) agency of the Republic of the Philippines. The announcement was made at the 6th annual InterMET Asia conference in Singapore. Initiated in 2017, and formally commissioned this week, the technology partnership between PAGASA and Earth Networks is the first of its kind in the Philippines and surrounding regions, powered by a network of total lightning sensors and real-time automatic weather stations for mesoscale monitoring. Installed and operated together with Philippines partner West Point Engineering, the 10-year program includes: Real-time lightning detection powered by the Earth Networks Total Lightning Network On-the-ground weather monitoring via the Earth Networks W

Game of Thrones Winter is Coming™ Launches Worldwide26.3.2019 02:00:00 EETTiedote

Yoozoo Games, a leading game developer and publisher, today announced the global launch of Game of Thrones Winter is Coming™ , a real-time strategy PC browser game officially licensed by Warner Bros. Interactive Entertainment under license from HBO®. The game is now available in English, with additional languages to follow. HBO, Warner Bros. Interactive Entertainment and Yoozoo Games have collaborated to recreate Westeros on a massive scale, delivering an authentic and immersive multiplayer world laid out across the Seven Kingdoms – complete with major landmarks and castles from the epic TV series. The story begins immediately following the death of Eddard Stark, when the player emerges as a new Westeros lord or lady in his stead. Strategising starts in earnest in Game of Thrones Winter is Coming as players aim to build an impenetrable base, train a victorious army and recruit faithful followers from a pool of iconic characters. As players progress, they must continue to acquire the mi

bluebird bio Statement on European Regulatory Status of LentiGlobin™26.3.2019 01:40:00 EETTiedote

A third party press release was issued today stating that the EMA (European Medicines Agency) issued an approval for the conditional Marketing Authorization Application (MAA) for LentiGlobin™, bluebird bio’s investigational gene therapy for the treatment of transfusion dependent β-thalassemia (TDT). LentiGlobin for TDT is scheduled to be reviewed as part of the CHMP (Committee on Human Medicinal Products) meeting from March 25 – 28, however no opinion has been issued by the CHMP. If the CHMP’s opinion is issued it would then be reviewed by the European Commission (EC), which has the authority to grant approval for the use of LentiGlobin in the EU. About bluebird bio, Inc. bluebird bio is pioneering gene therapy with purpose. From our Cambridge, Mass., headquarters, we’re developing gene therapies for severe genetic diseases and cancer, with the goal that people facing potentially fatal conditions with limited treatment options can live their lives fully. Beyond our labs, we’re working

Celgene Submits Application to FDA for Ozanimod for the Treatment of Relapsing Forms of Multiple Sclerosis25.3.2019 23:30:00 EETTiedote

Celgene Corporation (NASDAQ:CELG) today announced that the Company has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for ozanimod for the treatment of adults with relapsing forms of multiple sclerosis (RMS). Ozanimod is an oral, sphingosine 1-phosphate (S1P) receptor modulator, which binds with high affinity selectively to S1P subtypes 1 (S1P1) and 5 (S1P5). The pivotal efficacy and safety data provided in the application result from the SUNBEAM™ and RADIANCE™ Part B phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled trials. “New oral treatment options with differentiated profiles like ozanimod are needed to help address an unmet need for people with relapsing forms of MS,” said Jay Backstrom, M.D., Chief Medical Officer for Celgene. “With concurrent applications in the U.S. and EU, we look forward to advancing this promising medicine through the regulatory review process to provide a new option for the treatment of RMS in

AVLT and UKTS Announce the European Medicines Agency’s Approval of the Conditional Marketing Authorization Application for Zynteglo™ (Previously Known as Lentiglobin™) Gene Therapy for the Treatment of Transfusion Dependent Beta Thalassaemia25.3.2019 22:50:00 EETTiedote

Associazione Veneta Lotta alla Talassemia (AVLT) and the UK Thalassaemia Society (UKTS) announced today that the European Medicines Agency (EMA) has approved bluebird bio’s application for Conditional Marketing Authorization (cMAA) of their product Zynteglo™, a gene therapy for the treatment of adolescents and adults with transfusion-dependent β-thalassaemia (TDT) who do not have a β0/β0 genotype. As a result of this marketing authorisation, Zynteglo™ is now approved for use in all European countries covered by the European Medicines Agency. Zynteglo™ has been given ‘conditional authorisation’. This means that there is more evidence to be submitted, which the company is required to provide under specific obligations. Every year, the EMA will review any new information that becomes available. “People living with transfusion-dependent β-thalassaemia have a reduced life expectancy, requiring life-long frequent blood transfusions that are life-saving but may lead to complications, includin

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme